United Therapeutics reported $300.5M in EBITDA for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebitda Change
Amarin AMRN:US $ -27.53M 44.04M
Ardelyx ARDX:US $ -27.58M 4.9M
Baxter International BAX:US $ 911M 27M
Biocryst Pharmaceuticals BCRX:US $ -49.64M 2.37M
Biogen BIIB:US $ 674.7M 20.2M
Biomarin Pharmaceutical BMRN:US $ 56.67M 96.56M
Emergent Biosolutions EBS:US $ 37.3M 311M
Esperion Therapeutics ESPR:US $ -42836000 611K
Gilead Sciences GILD:US $ 3422M 1947M
GlaxoSmithKline GSK:LN 3120M 1062M
Halozyme Therapeutics HALO:US $ 76.45M 19.11M
Insmed INSM:US $ -98173000 1.78M
Intercept Pharmaceuticals ICPT:US $ -9.9M 10.55M
Intra Cellular Therapies ITCI:US $ -72.49M 13.37M
Johnson & Johnson JNJ:US $ 9309M 1549M
Lexicon Pharmaceuticals LXRX:US $ -23.27M 1.95M
Moderna Inc MRNA:US 4.31B 1.18B
Pfizer PFE:US $ 11182M 4046M
Ptc Therapeutics PTCT:US $ -60.21M 5.71M
Regeneron Pharmaceuticals REGN:US $ 1360.9M 1353.3M
Sangamo Biosciences SGMO:US $ -42.43M 5.29M
Sarepta Therapeutics SRPT:US $ -76.16M 19.51M
Seattle Genetics SGEN:US $ -115.96M 37.85M
Teva Pharmaceutical TEVA:IT 1.11B 176M
United Therapeutics UTHR:US $ 300.5M 117.1M
Vertex Pharmaceuticals VRTX:US $ 1069.3M 159.74M